Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Mier

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 22, 2017
Integration of CT urography improves diagnostic confidence of <sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patientsLeon Will, Frederik L Giesel, Martin T Freitag, et al.
Immunobiology|June 22, 2026
Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytesGabriel Gomis, Saioa Arrieta-Aranzueque, Claudia Herrero, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with <sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic TumorsAndreas Helisch, Clemens Kratochwil, Christian Kleist, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 11, 2026
Balancing Stealth and Targetability: cCPP- and PEG-Modified Liposomes for the Targeted Delivery of Anti-HER2 NanobodiesGiulia Pander, Maria Del Pilar Palacios Cisneros, Clara Certa, et al.
Frontiers in Chemistry|August 26, 2022
Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2017
Diagnostic performance of <sup>68</sup>Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patientsAli Afshar-Oromieh, Tim Holland-Letz, Frederik L Giesel, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2025
Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's diseaseLena Rehra, Susanne Erdinger, Lelia Wagner, et al.
Gastroenterology|November 25, 2015
Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 SignalingAlexandra Matzke-Ogi, Katharina Jannasch, Marine Shatirishvili, et al.
Elife|July 24, 2019
Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptideDominik Witzigmann, Philipp Uhl, Sandro Sieber, et al.
The Journal of Clinical Investigation|July 12, 2005
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesisArmin Schneider, Carola Krüger, Tobias Steigleder, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 22, 2017
Integration of CT urography improves diagnostic confidence of <sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patientsLeon Will, Frederik L Giesel, Martin T Freitag, et al.
Immunobiology|June 22, 2026
Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytesGabriel Gomis, Saioa Arrieta-Aranzueque, Claudia Herrero, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with <sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic TumorsAndreas Helisch, Clemens Kratochwil, Christian Kleist, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 11, 2026
Balancing Stealth and Targetability: cCPP- and PEG-Modified Liposomes for the Targeted Delivery of Anti-HER2 NanobodiesGiulia Pander, Maria Del Pilar Palacios Cisneros, Clara Certa, et al.
Frontiers in Chemistry|August 26, 2022
Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2017
Diagnostic performance of <sup>68</sup>Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patientsAli Afshar-Oromieh, Tim Holland-Letz, Frederik L Giesel, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2025
Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's diseaseLena Rehra, Susanne Erdinger, Lelia Wagner, et al.
Gastroenterology|November 25, 2015
Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 SignalingAlexandra Matzke-Ogi, Katharina Jannasch, Marine Shatirishvili, et al.
Elife|July 24, 2019
Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptideDominik Witzigmann, Philipp Uhl, Sandro Sieber, et al.
The Journal of Clinical Investigation|July 12, 2005
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesisArmin Schneider, Carola Krüger, Tobias Steigleder, et al.
Pageof 19